Serum Institute of India (SII) and Bharat Biotech have pledged to ensure global access to their vaccines against the coronavirus disease (Covid-19). “We are fully aware of the importance of vaccines for people and countries alike. We hereby communicate our joint pledge to provide global access for our Covid-19 vaccines,” SII and Bharat Biotech said in a joint statement, according to ANI.
The statement said that SII’s Adar Poonawalla and Bharat Biotech’s Krishna Ella are focusing on manufacturing, supply and distribution of the vaccines. The joint statement said that both companies are fully engaged in this activity and consider it as their duty to provide the vaccines to the citizens and people worldwide.
Also Read: Exports of Covishield allowed to all countries, clarifies Adar Poonawalla
“Mr. Adar Poonawala and Dr. Krishna Ella, jointly on behalf of the two Companies, today communicated their combined intent to develop manufacture and supply the COVID-19 vaccines for India and globally. They said, the more important task in front of them is saving the lives and livelihoods of populations in India and the world. Vaccines are a global public health good and they have the power to save lives and accelerate the return to economic normalcy at the earliest,” the statement said.
“Now that two COVID-19 vaccines have been issued EUA (emergency use authorization) in India, the focus is on manufacturing, supply and distribution, such that populations that need it the most receive high quality, safe and efficacious vaccines,” the statement further said.
The statement comes after some medical industry experts and opposition leaders expressed concern over the lack of Phase III trial data of Covaxin. Congress leader Manish Tewari on Tuesday to lashed out at the Centre said the approval given to the vaccines was ‘premature’ and accused the government of sidestepping important processes.
He told news agency ANI that the governments has misused the pandemic for political purposes and raised questions regarding the reliability of the vaccines.
Bharat Biotech’s Dr Krishna Ella on Monday lashed out at his detractors and said, “We do 200 percent honest clinical trials and yet we receive backlash.”
“If I am wrong, tell me. Some companies have branded me like water,” Ella was quoted as saying by news agency PTI. Earlier on Monday, SII CEO Poonawalla had termed vaccines other than that of Pfizer, Moderna and Oxford-AstraZeneca as ‘just like water.’
In their joint statement both Poonawalla and Ella have said that they have pledged to provide global access to the vaccines developed by them. “Both our Companies are fully engaged in this activity and consider it our duty to the nation and the world at large to ensure a smooth rollout of vaccines. Each of our Companies continue their COVID-19 vaccines development activities as planned. We are fully aware of the importance of vaccines for people and countries alike, we hereby communicate our joint pledge to provide global access for our COVID-19 vaccines.”